0000016058-20-000094.txt : 20201005 0000016058-20-000094.hdr.sgml : 20201005 20201005203937 ACCESSION NUMBER: 0000016058-20-000094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201001 FILED AS OF DATE: 20201005 DATE AS OF CHANGE: 20201005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LONDON J PHILLIP CENTRAL INDEX KEY: 0001230973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31400 FILM NUMBER: 201225308 MAIL ADDRESS: STREET 1: 1100 N GLEBE ROAD CITY: ARLINGTON STATE: VA ZIP: 22201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CACI INTERNATIONAL INC /DE/ CENTRAL INDEX KEY: 0000016058 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 541345888 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1100 N GLEBE ST CITY: ARLINGTON STATE: VA ZIP: 22201 BUSINESS PHONE: 7038417800 MAIL ADDRESS: STREET 1: 1100 NORTH GLEBE ROAD CITY: ARLINGTON STATE: VA ZIP: 22201 FORMER COMPANY: FORMER CONFORMED NAME: CACI INC /DE/ DATE OF NAME CHANGE: 19870119 FORMER COMPANY: FORMER CONFORMED NAME: CONSOLIDATED ANALYSIS CENTERS INC DATE OF NAME CHANGE: 19730102 FORMER COMPANY: FORMER CONFORMED NAME: CALIFORNIA ANALYSIS CENTER INC DATE OF NAME CHANGE: 19680603 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2020-10-01 0000016058 CACI INTERNATIONAL INC /DE/ CACI 0001230973 LONDON J PHILLIP 1100 N. GLEBE ROAD ARLINGTON VA 22201 1 0 0 0 CACI Common Stock 2020-10-01 4 M 0 7252 A 92388 D CACI Common Stock 2020-10-01 4 F 0 3272 215.23 D 89116 D CACI Common Stock 2020-10-01 4 M 0 5766 A 94882 D CACI Common Stock 2020-10-01 4 F 0 2602 215.23 D 92280 D CACI Common Stock (Restricted Stock Units) 2020-10-01 4 M 0 7252 D CACI Common Stock 7252 44794 D CACI Common Stock (Restricted Stock Units) 2020-10-01 4 M 0 5766 D CACI Common Stock 5766 39028 D On 9/30/16, Dr. London was granted restricted stock units that convert into 7,252 shares of common stock on a 1 for 1 basis. These restricted stock units vested on 10/1/20. on 9/15/2017, Dr. London was granted restricted stock units that convert into 5,766 shares of common stock on a 1 for 1 basis. These restricted stock units vested on 10/1/20. J. Phillip London 2020-10-05